Correlation between allopregnanolone levels and depressive symptoms during late menopausal transition and early postmenopause

References

• Baulieu EE. Neurosteroids: a new function in the brain. Biol Cell 1991;71:3–10.
   PubMed Web of Science ®Google Scholar
• Robel P, Baulieu EE. Neurosteroids. Biosynthesis and function. Trends Endocrinol Metab 1994;5:1–8.
   PubMed Web of Science ®Google Scholar
• Melcangi RC, Celotti F, Castano P, Martini L. Differential localization of the 5 alpha-reductase and the 3 alpha-hydroxysteroid dehydrogenase in neuronal and glial cultures. Endocrinology 1993;132:1252–9.
   PubMed Web of Science ®Google Scholar
• Petratos S, Hirst JJ, Mendis S, et al. Localization of p450scc and 5alpha-reductase type-2 in the cerebellum of fetal and newborn sheep. Brain Res Dev Brain Res 2000; 123:81–6.
   PubMedGoogle Scholar
• Stoffel-Wagner B. Neurosteroid metabolism in the human brain. Eur J Endocrinol 2001;145:669–79.
   PubMed Web of Science ®Google Scholar
• Stoffel-Wagner B, Watzka M, Steckelbroeck S, et al. Allopregnanolone serum levels and expression of 5 alpha-reductase and 3 alpha hydroxysteroid dehydrogenase isoforms in hippocampal and temporal cortex of patients with epilepsy. Epilepsy Res 2003;54:11–19.
   PubMed Web of Science ®Google Scholar
• Waraich P, Goldner EM, Somers JM, Hsu L. Prevalence and incidence studies of mood disorders: a systematic review of the literature. Can J Psychiatry 2004;49:124–38.
   PubMed Web of Science ®Google Scholar
• Olsen RW, Siegart W. International Union of Pharmacology. Subtypes of gamma aminobutyric acid a receptors: classification on the basis of subunit composition, pharmacology and function. Pharmacol Rev 2008;60:243–60.
   PubMed Web of Science ®Google Scholar
• Sundstrom I, Andersson A, Nyberg S, et al. Patients with premenstrual syndrome have a different sensitivity to a neuroactive steroid during the menstrual cycle compared to control subjects. Neuroendocrinology 1998;67:126–38.
   PubMed Web of Science ®Google Scholar
• Khisti RT, Mandhane SN, Chopde CT. The neurosteroid 3-alpha-hydroxy-5-alpha-pregnan-20-one induces catalepsy in mice. Neurosci Lett 1998;251:85–8.
   PubMed Web of Science ®Google Scholar
• Johansson IM, Birzniece V, Lindblad C, et al. Allopregnanolone inhibits learning in the Morris water maze. Brain Res 2002;934:125–31.
   PubMed Web of Science ®Google Scholar
• Miller MN, Miller BE. Premenstrual exacerbations of mood disorders. Psychopharmacol Bull 2001;35:135–49.
   PubMedGoogle Scholar
• Pisu MG, Serra M. Neurosteroids and neuroactive drugs in mental disorders. Life Sci 2004;74:3181–97.
   PubMed Web of Science ®Google Scholar
• Nappi RE, Petraglia F, Luisi S, et al. Serum allopregnanolone in women with postpartum “blues”. Obstet Gynecol 2001;97:77–80.
   PubMed Web of Science ®Google Scholar
• Eser D, Schüle C, Baghai TC, et al. Neuroactive steroids in depression and anxiety disorders: clinical studies. Neuroendocrinology 2006;84:244–54.
   PubMed Web of Science ®Google Scholar
• Uzunova V, Sheline Y, Davis JM, et al. Increase in the cerebrospinal fluid content of neurosteroids in patients with unipolar major depression who are receiving fluoxetine or fluvoxamine. Proc Natl Acad Sci USA 1998;95:3239–44.
   PubMed Web of Science ®Google Scholar
• Charalampopoulos I, Remboutsika E, Margioris AN, Gravanis A. Neurosteroids as modulators of neurogenesis and neuronal survival. Trends Endocrinol Metab 2008;19:300–7.
   PubMed Web of Science ®Google Scholar
• Bessa JM, Ferreira D, Melo I, et al. The mood-improving actions of antidepressants do not depend on neurogenesis but are associated with neuronal remodeling. Mol Psychiatry 2009;14:764–73.
   PubMed Web of Science ®Google Scholar
• Maartens L, Knottnerus J, Pop V. Menopausal transition and increased depressive symptomatology. A community based prospective study. Maturitas 2002;42:195.
   PubMed Web of Science ®Google Scholar
• Bromberger JT, Schott LL, Kravitz HM, et al. Longitudinal change in reproductive hormones and depressive symptoms across the menopausal transition: results from the study of women’s health across the nation (SWAN). Arch Gen Psychiatry 2010;67:598–607.
   PubMed Web of Science ®Google Scholar
• Kraepelin E. Manic-depressive insanity and paranoia. Edinburgh (Scotland): Livingstone; 1921.
   Google Scholar
• Ballinger CB. Psychiatric morbidity and the menopause; screening of general population sample. Br Med J 1975;3:344–6.
   PubMed Web of Science ®Google Scholar
• Freeman EW, Sammel MD, Liu L, et al. Hormones and menopausal status as predictors of depression in women in transition to menopause. Arch Gen Psychiatry 2004;61:62–70.
   PubMed Web of Science ®Google Scholar
• Genazzani AR, Bernardi F, Pluchino N, et al. Endocrinology of menopausal transition and its brain implications. CNS Spectr 2005;10:449–57.
   PubMed Web of Science ®Google Scholar
• Słopień R, Junik R, Męczekalski B, et al. Influence of hormonal replacement therapy on the regional cerebral blood flow in postmenopausal women. Maturitas 2003;46:255–62.
   PubMed Web of Science ®Google Scholar
• Słopień R, Jaśniewicz J, Męczekalski B, et al. Polymorphic variants of genes encoding MTHFR, MTR and MTHFD1 and the risk of depression in postmenopausal women in Poland. Maturitas 2008;8:252–5.
   Google Scholar
• Harlow SD, Gass M, Hall JE, et al. Executive summary of the stages of reproductive aging workshop. Addressing the unfinished agenda of staging reproductive aging. J Clin Endocrinol Metab 2012;97:1159–68.
   Web of Science ®Google Scholar
• Kupperman HS, Blatt MH, Wiesbader H, Filler W. Comparative clinical evaluation of estrogenic preparations by the menopausal and amenorrheal indices. J Clin Endocrinol Metab 1953;13:688–703.
   PubMed Web of Science ®Google Scholar
• Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960;23:56–62.
   PubMed Web of Science ®Google Scholar
• Genazzani AR, Petraglia F, Bernardi F, et al. Circulating levels of allopregnanolone in humans: gender, age, and endocrine influences. J Clin Endocrinol Metab 1998;83:2099–103.
   PubMed Web of Science ®Google Scholar
• Bernardi F, Pieri M, Stomati M, et al. Effect of different hormonal replacement therapies on circulating allopregnanolone and dehydroepiandrosterone levels in postmenopausal women. Gynecol Endocrinol 2003;17:65–77.
   PubMed Web of Science ®Google Scholar
• Barbaccia ML, Lello S, Sidiropoulou T, et al. Plasma 5alpha-androstane-3alpha,17betadiol, an endogenous steroid that positively modulates GABA (A) receptor function, and anxiety: a study in menopausal women. Psychoneuroendocrinology 2000;25:659–75.
   PubMed Web of Science ®Google Scholar
• Pinna G, Costa E, Guidotti A. SSRIs act as selective brain steroidogenic stimulants (SBSSs) at low doses that are inactive on 5-HT reuptake. Curr Opin Pharmacol 2009;9:24–30.
   PubMed Web of Science ®Google Scholar
• Andréen L, Sundström-Poromaa I, Bixo M, et al. Relationship between allopregnanolone and negative mood in postmenopausal women taking sequential hormone replacement therapy with vaginal progesterone. Psychoneuroendocrinology 2005;30:212–24.
   PubMed Web of Science ®Google Scholar
• Rapkin AJ, Morgan M, Sogliano C, et al. Decreased neuroactive steroids induced by combined oral contraceptive pills are not associated with mood changes. Fertil Steril 2006;85:1371–8.
   PubMed Web of Science ®Google Scholar
• Frye CA, Duncan JE. Progesterone metabolites, effective at the GABAA receptor complex, attenuate pain sensitivity in rats. Brain Res 1994;643:194–203.
   PubMed Web of Science ®Google Scholar
• Kehoe P, Mallinson K, McCormick CM, Frye CA. Central allopregnanolone is increased in rat pups in response to repeated, short episodes of neonatal isolation. Dev Brain Res 2000;124:133–6.
   PubMedGoogle Scholar
• Djebaili M, Guo Q, Pettus EH, et al. The neurosteroids progesterone and allopregnanolone reduce cell death, gliosis, and functional deficits after traumatic brain injury in rats. J Neurotrauma 2005;22:106–18.
   PubMed Web of Science ®Google Scholar
• Glantz LA, Gilmore JH, Overstreet DH, et al. Pro-apoptotic Par-4 and dopamine D2 receptor in temporal cortex in schizophrenia, bipolar disorder and major depression. Schizophr Res 2010;118:292–9.
   PubMed Web of Science ®Google Scholar
• He J, Evans C-O, Hoffman SW, et al. Progesterone and allopregnanolone reduce inflammatory cytokines after traumatic brain injury. Exp Neurol 2004;189:404–12.
   PubMed Web of Science ®Google Scholar
• Korneyev A, Costa E. Allopregnanolone (THP) mediates anesthetic effects of progesterone in rat brain. Horm Behav 1996;30:37–43.
   PubMed Web of Science ®Google Scholar
• Mok WM, Bukusoglu C, Krieger NR. 3a-Hydroxy-5a-pregnan-20-one is the only active anesthetic steroid in anesthetized mouse brain. Steroids 1993;58:112–14.
   PubMed Web of Science ®Google Scholar
• Lancel M, Faulhaber J, Schiffelholz T, et al. Allopregnanolone affects sleep in a benzodiazepine-like fashion. J Pharmacol Exp Ther 1997;282:1213–18.
   PubMed Web of Science ®Google Scholar
• Genazzani AR, Palumbo MA, de Micheroux AA, et al. Evidence for a role for the neurosteroid allopregnanolone in the modulation of reproductive function in female rats. Eur J Endocrinol 1995;133:375–80.
   PubMed Web of Science ®Google Scholar
• Petralia SM, Frye CA. In the ventraltegmental area picrotoxin blocks FGIN 1-27-induced increases in sexual behavior of rats and hamsters. Psychopharmacology (Berl) 2005;178:174–82.
   PubMed Web of Science ®Google Scholar
• Nappi RE, Abbiati I, Luisi S, et al. Serum allopregnanolone relate to FSFI score during the menstrual cycle. J Sex Marital Ther 2003;29:95–102.
   PubMed Web of Science ®Google Scholar
• Santoru F, Berretti R, Locci A, et al. Decreased allopregnanolone induced by hormonal contraceptives is associated with a reduction in social behavior and sexual motivation in female rats. Psychopharmacology (Berl) 2014;231:3351–64.
   PubMed Web of Science ®Google Scholar
• Frye CA, Rhodes ME. Fluoxetine-induced decrements in sexual responses of female rats and hamsters are reversed by 3α,5α-THP. J Sex Med 2010;7:2670–80.
   PubMed Web of Science ®Google Scholar
• Riedel M, Möller HJ, Obermeier M, et al. Response and remission criteria in major depression: a validation of current practice. J Psychiatr Res 2010;44:1063–8.
   PubMed Web of Science ®Google Scholar
• Bagby RM, Ryder AG, Schuller DR, Marshall MB. The Hamilton Depression Rating Scale: Has the gold standard become a lead weight? Am J Psychiatry 2004;161:2163–77.
   PubMed Web of Science ®Google Scholar
• Vaccarino AL, Evans KR, Kalali AH, et al. The depression inventory development workgroup: a collaborative, empirically driven initiative to develop a new assessment tool for major depressive disorder. Innov Clin Neurosci 2016;13:20–31.
   PubMedGoogle Scholar